Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction
B. Schittek et al., Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction, BR J DERM, 141(1), 1999, pp. 37-43
Conflicting results have been obtained by various research groups using tyr
osinase reverse transcription-polymerase chain reaction (RT-PCR) for detect
ing micrometastases in the blood of melanoma patients, with positive result
s ranging from 0 to 100% in disseminated melanoma, Methodological differenc
es in the processing of blood samples may in part account for these discrep
ancies. The aim of this study was to standardize and optimize the experimen
tal conditions for RT-PCR detection of melanoma cells in peripheral blood.
We analysed the effect of different parameters of sample processing on the
sensitivity of the tyrosinase RT-PCR using peripheral blood spiked with def
ined numbers of SKMEL28 melanoma cells. Purification of the mononuclear cel
l fraction using a Ficoll gradient with a density of 1.077 g/mL prior to RN
A isolation gave the highest sensitivity, with the detection of two SKMEL28
cells in 5 mL, of blood. In addition, the RNA isolation method and the kin
d of RT enzyme used had a significant impact on the sensitivity and reprodu
cibility of tyrosinase detection, whereas variations in the PCR conditions
had only a minor influence. Furthermore, we showed that amplification of Me
lanA in addition to tyrosinase resulted in an approximately 10% enhanced se
nsitivity of melanoma cell detection, whereas gp1w00/pMel17 and MUC18 gene
products were also detected in blood from non-melanoma patients, MelanA cou
ld serve as a sensitive marker in addition to tyrosinase for detecting micr
ometastases.